» Articles » PMID: 25356311

Examining Sexual Dysfunction in Non-muscle-invasive Bladder Cancer: Results of Cross-sectional Mixed-methods Research

Overview
Journal Sex Med
Date 2014 Oct 31
PMID 25356311
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: More than 70,000 new cases of bladder cancer are diagnosed in the United States annually; with 75% being non-muscle-invasive (NMIBC). Research examining sexual dysfunction in bladder cancer survivors is limited, and previous studies have focused on cystectomy patients.

Aims: To evaluate the impact of sexual dysfunction on NMIBC survivors.

Methods: Mixed-methods data collection integrated a quantitative survey (Study 1; n = 117) and semi-structured qualitative interviews (Study 2; n = 26) from a non-overlapping sample of NMIBC survivors. We performed descriptive and classification and regression tree (CART) analyses of survey data and qualitative analysis of interviews.

Main Outcome Measures: Self-reported sexual activity, interest in sex, and physiologic symptoms (e.g., male erectile/ejaculatory difficulties, female vaginal dryness) over the previous 4 weeks; partner communication about sexuality; contamination concerns; illness intrusiveness.

Results: Participants in these studies averaged 65 years of age (mean and median) and were male (77%), white (91%), and married (75%). Survey (Study 1) results linked NMIBC treatment to sexual symptoms and relationship issues. Many participants reported sexual inactivity (38.8%). Sexually active participants reported erectile difficulties (60.0%), vaginal dryness (62.5%), and worry about contaminating partner with treatment agents (23.2%). While almost one-half reported the usefulness of talking with partners about sexual function, only one-fifth of participants reported sharing all concerns with their partners. CART analysis supported the importance of communication. One-half of interviewees (Study 2) reported sexual dysfunction. Two-thirds reported negative impacts on their relationships, including perceived loss of intimacy and divorce; over one-third were sexually inactive for fear of contaminating their partner or spreading NMIBC.

Conclusions: Survivors' sexual symptoms may result from NMIBC, comorbidities, or both. These results inform literature and practice by raising awareness about the frequency of symptoms and the impact on NMIBC survivors' intimate relationships. Further work is needed to design symptom management education programs to dispel misinformation about contamination post-treatment and improve quality of life. Kowalkowski MA, Chandrashekar A, Amiel GE, Lerner SP, Wittmann DA, Latini DM, and Goltz HH. Examining sexual dysfunction in non-muscle-invasive bladder cancer: Results of cross-sectional mixed-methods research. Sex Med 2014;2:141-151.

Citing Articles

Perceived academic stress during a pandemic: Mediating role of coping strategies.

Rahiman H, Panakaje N, Kulal A, Harinakshi , Riha Parvin S Heliyon. 2023; 9(6):e16594.

PMID: 37287604 PMC: 10232934. DOI: 10.1016/j.heliyon.2023.e16594.


Female sexual function in bladder cancer: A review of the evidence.

Martin R, Renouf T, Rigby J, Hafeez S, Thurairaja R, Kumar P BJUI Compass. 2022; 4(1):5-23.

PMID: 36569507 PMC: 9766865. DOI: 10.1002/bco2.186.


Evaluation of supportive care needs, sexuality and quality of life in phase 1 trials: a prospective monocentric study.

Hilmi M, Naoun N, Boileve A, Geraud A, Bayle A, Pages A Support Care Cancer. 2022; 30(12):9841-9849.

PMID: 36271944 DOI: 10.1007/s00520-022-07407-6.


Is It Time for a "Me-Too" Movement Against Attitudes Towards Women Suffering from Nongynecological Malignancies?.

Shashar R, Amiel G J Cancer Educ. 2021; 36(5):897-898.

PMID: 34550558 DOI: 10.1007/s13187-021-02092-1.


Quality of life in patients undergoing surveillance for non-muscle invasive bladder cancer-a systematic review.

Nayak A, Cresswell J, Mariappan P Transl Androl Urol. 2021; 10(6):2737-2749.

PMID: 34295759 PMC: 8261437. DOI: 10.21037/tau-20-1333.


References
1.
Laumann E, Paik A, Rosen R . Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999; 281(6):537-44. DOI: 10.1001/jama.281.6.537. View

2.
Stav K, Leibovici D, Goren E, Livshitz A, Siegel Y, Lindner A . Adverse effects of cystoscopy and its impact on patients' quality of life and sexual performance. Isr Med Assoc J. 2004; 6(8):474-8. View

3.
van der Aa M, Bekker M, van der Kwast T, Essink-Bot M, Steyerberg E, Zwarthoff E . Sexual function of patients under surveillance for bladder cancer. BJU Int. 2009; 104(1):35-40. DOI: 10.1111/j.1464-410X.2008.08333.x. View

4.
Allareddy V, Kennedy J, West M, Konety B . Quality of life in long-term survivors of bladder cancer. Cancer. 2006; 106(11):2355-62. DOI: 10.1002/cncr.21896. View

5.
Flynn K, Jeffery D, Keefe F, Porter L, Shelby R, Fawzy M . Sexual functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS®). Psychooncology. 2010; 20(4):378-86. PMC: 3013236. DOI: 10.1002/pon.1738. View